Disease Information & Support


The Word:


Generic name Hydroxyurea
Pronunciation hy-DROK-see-yoo-REE-ah
Brand name(s), other common name(s) Droxia®, Hydrea®
Drug type  Antimetabolite
How the drug is given By mouth

Hydroxyurea is FDA approved to treat people who have chronic myelocytic leukemia and some other blood cancers, including essential thrombocythemia and polycythemia vera. Hydroxyurea may cause temporary loss of hair in some people. After treatment has ended, normal hair growth should return, although the new hair may be a slightly different color or texture.

Side effects needing medical attention: Fever; chills; sore throat; sores in mouth and on lips; unusual bleeding or bruising; convulsions; unusual tiredness or fatigue; dizziness; side or stomach pain; hallucinations (seeing, hearing or feeling things that are not there); headache; joint pain; confusion; diarrhea; constipation; drowsiness; redness of face; loss of appetite; nausea; vomiting.

Side effects needing medical attention after stopping this medication: Black, tarry stools; blood in urine; cough or hoarseness; fever or chills; lower back or side pain; painful or difficult urination; pinhead-sized red spots on skin; unusual bleeding or bruising.


For information on how to manage the costs of drug therapy, please see Financial Matters and Prescription Drug Coverage, or to speak with an Information Specialist, call (800) 955-4572.

last updated on Monday, October 15, 2012